Akanda Corp. (AKAN)

USD 1.2

(-1.64%)

Total Assets Summary of Akanda Corp.

  • Akanda Corp.'s latest annual total assets in 2023 was 8.83 Million USD , down -77.33% from previous year.
  • Akanda Corp.'s latest quarterly total assets in 2024 Q2 was 9.96 Million USD , down 0.0% from previous quarter.
  • Akanda Corp. reported annual total assets of 38.99 Million USD in 2022, up 384.67% from previous year.
  • Akanda Corp. reported annual total assets of 8.04 Million USD in 2021, up 88.22% from previous year.
  • Akanda Corp. reported quarterly total assets of 36.5 Million USD for 2023 Q2, down 0.0% from previous quarter.
  • Akanda Corp. reported quarterly total assets of 8.83 Million USD for 2023 FY, down -77.33% from previous quarter.

Annual Total Assets Chart of Akanda Corp. (2023 - 2019)

Historical Annual Total Assets of Akanda Corp. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 8.83 Million USD -77.33%
2022 38.99 Million USD 384.67%
2021 8.04 Million USD 88.22%
2020 4.27 Million USD 0.0%
2019 - USD 0.0%

Peer Total Assets Comparison of Akanda Corp.

Name Total Assets Total Assets Difference
Cosmos Health Inc. 66.29 Million USD 86.666%
Safety Shot Inc 12.7 Million USD 30.444%
Bright Green Corporation 17.4 Million USD 49.204%
Embecta Corp. 1.21 Billion USD 99.272%
ANI Pharmaceuticals, Inc. 904.42 Million USD 99.023%
Aquestive Therapeutics, Inc. 57.41 Million USD 84.604%
Collegium Pharmaceutical, Inc. 1.14 Billion USD 99.227%
Dynavax Technologies Corporation 997.09 Million USD 99.113%
Esperion Therapeutics, Inc. 205.79 Million USD 95.704%
Intra-Cellular Therapies, Inc. 728.29 Million USD 98.786%
Pacira BioSciences, Inc. 1.57 Billion USD 99.439%
PainReform Ltd. 9.93 Million USD 10.977%
Sunshine Biopharma, Inc. 27.34 Million USD 67.675%
Sunshine Biopharma, Inc. 27.34 Million USD 67.675%
SCYNEXIS, Inc. 128.41 Million USD 93.116%
China SXT Pharmaceuticals, Inc. 23.12 Million USD 61.776%
Journey Medical Corporation 76.84 Million USD 88.497%
Alpha Teknova, Inc. 128.58 Million USD 93.125%
Procaps Group, S.A. 460.18 Million USD 98.079%
Theratechnologies Inc. 77.76 Million USD 88.633%
Harrow Health, Inc. 311.75 Million USD 97.164%
Sonoma Pharmaceuticals, Inc. 14.89 Million USD 40.643%
Biofrontera Inc. 27.93 Million USD 68.352%
DURECT Corporation 45.18 Million USD 80.438%
Supernus Pharmaceuticals, Inc. 1.4 Billion USD 99.373%
Cronos Group Inc. 1.13 Billion USD 99.221%
OptiNose, Inc. 107.72 Million USD 91.794%
Ironwood Pharmaceuticals, Inc. 471.07 Million USD 98.123%
Kala Pharmaceuticals, Inc. 55.94 Million USD 84.2%
RedHill Biopharma Ltd. 23.04 Million USD 61.644%
Organogenesis Holdings Inc. 460.02 Million USD 98.078%
Guardion Health Sciences, Inc. 11.91 Million USD 25.828%
Cumberland Pharmaceuticals Inc. 81.77 Million USD 89.19%
Radius Health, Inc. 1.71 Billion USD 99.485%
Universe Pharmaceuticals INC 53.28 Million USD 83.411%
ProPhase Labs, Inc. 91.92 Million USD 90.384%
Phibro Animal Health Corporation 982.18 Million USD 99.1%
Procaps Group S.A. 460.18 Million USD 98.079%
Alvotech 950.09 Million USD 99.07%
TherapeuticsMD, Inc. 43.3 Million USD 79.589%
Viatris Inc. 47.68 Billion USD 99.981%
Rockwell Medical, Inc. 52.17 Million USD 83.056%
Aytu BioPharma, Inc. 118.09 Million USD 92.515%
SIGA Technologies, Inc. 254.83 Million USD 96.531%
Tilray Brands, Inc. 4.33 Billion USD 99.796%
Lifecore Biomedical, Inc. 273.7 Million USD 96.77%
Shineco, Inc. 84.17 Million USD 89.499%
PetIQ, Inc. 868.22 Million USD 98.982%
Regencell Bioscience Holdings Limited 8.43 Million USD -4.761%
Incannex Healthcare Limited 17.04 Million USD 48.143%
Neurocrine Biosciences, Inc. 3.25 Billion USD 99.728%
Alimera Sciences, Inc. 153.52 Million USD 94.242%
Silver Spike Investment Corp. 88.57 Million USD 90.02%
Assertio Holdings, Inc. 286.41 Million USD 96.914%
Shuttle Pharmaceuticals Holdings, Inc. 5.95 Million USD -48.528%
Petros Pharmaceuticals, Inc. 33.79 Million USD 73.843%
Clever Leaves Holdings Inc. 31.24 Million USD 71.706%
Cyclo Therapeutics, Inc. 13.24 Million USD 33.271%
Avadel Pharmaceuticals plc 261.12 Million USD 96.615%
Hempacco Co., Inc. 18.04 Million USD 51.006%
Talphera, Inc. 20.39 Million USD 56.656%
Alvotech 950.09 Million USD 99.07%
Eagle Pharmaceuticals, Inc. 406.16 Million USD 97.824%
Lantheus Holdings, Inc. 1.65 Billion USD 99.465%
Currenc Group, Inc. 141.49 Million USD 93.752%
Kamada Ltd. 351.96 Million USD 97.488%
Indivior PLC 1.95 Billion USD 99.547%
Evoke Pharma, Inc. 7.06 Million USD -25.061%
Flora Growth Corp. 23.62 Million USD 62.584%
Cyclo Therapeutics, Inc. 13.24 Million USD 33.271%
Evolus, Inc. 188.99 Million USD 95.323%
HUTCHMED (China) Limited 1.27 Billion USD 99.309%
Amphastar Pharmaceuticals, Inc. 1.51 Billion USD 99.416%